Myriad Genetics Blog Blog > Consistent data matters. Prolaris® is the best answer for your prostate cancer patients. Submit the form below to learn why. Consistent data matters. Prolaris® is the best answer for your prostate cancer patients. Submit the form below to learn why. August 26, 2022 Provider Blog Urology Treating prostate cancer can be hard, Prolaris makes it easy Knowing if your prostate cancer patients are safe for active surveillance or if they would benefit from active treatment can be challenging. The Prolaris white paper tells our exclusive story of consistent data across our validation and utility studies; giving you confidence to choose Prolaris when making treatment decisions between AS and active treatment. Request Prolaris White Paper If for some reason you don’t receive the email with your white paper download, make sure to check your junk folder. Physician First Name Physician Last Name Email NPI Number SpecialtyPlease select... Urology Urologic Oncology Radiation Oncology Pathology Zip Code How can we help? Hidden Fields Google Account ID Web_Form_URL__c Google_Client_Id__c GCLID UTM Medium UTM Source UTM Campaign UTM Content UTM Term AE_Email AE_First_Name AE_Last_Name You agree to be contacted with newsletters, marketing or promotional materials and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in any email we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Policy. reCAPTCHA helps prevent automated form spam. The submit button will be disabled until you complete the CAPTCHA. Contact Information Learn how Prolaris can benefit your practice Order a Urologist Guide Order a Radiation Oncologist Guide